Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Reducción de Energía y Umami (Season)

6 de noviembre de 2026 actualizado por: Ciaran Forde, Wageningen University

Efectos Interactivos de la Intensidad del Sabor Umami y la Densidad Energética en la Ingesta Alimentaria a Largo Plazo

People tend to regulate intake by the weight of food rather than its energy content, making energy dense foods, especially those combining salty, fatty, and umami tastes, more likely to promote passive overconsumption. Lowering energy density can reduce daily energy intake, but often decreases palatability, whereas umami can enhance palatability, and sometimes decrease food intake. This suggests that adding umami to a regular energy dense diet could reduce food intake over time, and that adding umami to a reduced energy dense diet could sustain palatability and limit compensatory energy intake. Therefore, the aim of this study is to assess the effect of a 2-week dietary intervention of adding umami and/or lowering energy density on food intake. Secondary objectives are whether adding umami and/or lowering energy density affect dietary satisfaction, appetite, perceived umami intensity, food preferences, bodyweight and composition, and wellbeing ratings.

This will assessed in a double-blind crossover, randomized controlled trial of three times two weeks, each separated by two weeks washout in 33 healthy Dutch adults between 18-65 years of age, with a BMI between 20-30. Umami taste will be added through MSG supplementation of the three main meals. Supplementation will depend on both intervention group, and individual participants' body weight. Energy density will be lowered by swapping regular products for low-fat, low-sugar or higher water products.

The three intervention diets will vary in umami taste intensity, and/or energy density: 1) regular energy density without added umami (control), 2) regular energy density with added umami, 3) reduced energy density with added umami. Umami will be supplemented by supplementing food items with 55-60 mg MSG per kg bodyweight daily, divided over three eating occasions. Foods will be offered ad libitum, and participants will add a seasoning sachet containing MSG to their selected portion.

The primary objective will be to compare average daily food intake (kcal) over two weeks between the three dietary interventions differing in umami taste intensity and energy density. Secondary outcomes are dietary satisfaction, appetite, perceived umami intensity, food preferences, bodyweight and composition, and wellbeing ratings.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Gelderland
      • Wageningen, Gelderland, Países Bajos, 6708WE
        • Reclutamiento
        • Department of Human Nutrition, Wageningen University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Healthy: as judged by the participant;
  • Age 16-65 years at the time of inclusion, assessed by date of birth;
  • Proper understanding of the Dutch language, as questionnaires will be in Dutch;
  • Able to visit Wageningen University, as required for dietary intervention and testing;
  • Body mass index 20-30 kg/m2;
  • Having normal taste ability, assessed using Mueller taste strip test, ≥12 out of 20 assessed correctly.

Exclusion Criteria:

  • Suffering from endocrine- or gastro-intestinal diseases or other diseases that might influence study outcomes (such as diabetes, Crohn's disease, cardiovascular disease, hypertension, etc.);
  • Diagnosed with eating disorders (currently or in the past);
  • Diagnosed with taste or smell disorders in the past six months;
  • Pregnant or lactating during the study intervention;
  • Following a strict dietary regime;
  • Extreme physical activity (>10 hours per week moderate/high intensity exercise);
  • Gain or loss of more than 5 kgs in the last six months prior to study entry;
  • Suffering from lack of appetite for any reason;
  • Use of medication that may influence the appetite (medication will be judged by the medical investigator);
  • Having a food allergy and/or intolerance for foods used in the dietary intervention (e.g. lactose intolerance, gluten intolerance, MSG sensitivity). This will be assessed with an open question;
  • Consumes more than 14 (women) or 21 (men) glasses of alcohol per week;
  • Consumes MSG-rich sauces (soy sauce, ketjap and/or curry paste) more than once per day, or consumes more than 3 savoury food items (paprika chips, instant noodles, sundried tomatoes and/or pre-packaged seasonings) per day. This will be assessed with a frequency of consumption table;
  • Irregular eating pattern. This will be measured with a frequency of meal/food consumption table, and is defined as: frequency of breakfast consumption less than once per week;
  • Unwilling to maintain regular exercise pattern during the study period. This will be assessed with a yes/no question;
  • Unwilling to quit use of soft or hard drugs during the intervention;
  • Student or personnel of the division of Human Nutrition and Health, Wageningen University;
  • Participating in any other intervention study/studies or planning to participate in another intervention study during the study period.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Ciencia básica
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: regED/-MSG -> regED/+MSG -> lowED/+MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention lowED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Otros nombres:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • lowED/+MSG
Experimental: regED/-MSG -> lowED/-MSG -> regED/+MSG

Participants receive Intervention regED/-MSG in Period 1, Intervention lowED/+MSG in Period 2, and Intervention regED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Otros nombres:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • lowED/+MSG
Experimental: regED/+MSG -> lowED/+MSG -> regED/-MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention lowED/+MSG in Period 2, and Intervention regED/-MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Otros nombres:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • lowED/+MSG
Experimental: regED/+MSG -> regED/-MSG -> lowED/+MSG

Participants receive Intervention regED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention lowED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Otros nombres:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • lowED/+MSG
Experimental: lowED/+MSG -> regED/+MSG -> regED/-MSG

Participants receive Intervention lowED/+MSG in Period 1, Intervention regED/+MSG in Period 2, and Intervention regED/-MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Otros nombres:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • lowED/+MSG
Experimental: lowED/+MSG -> regED/-MSG -> regED/+MSG

Participants receive Intervention lowED/+MSG in Period 1, Intervention regED/-MSG in Period 2, and Intervention regED/+MSG in Period 3.

During this intervention, participants will receive a Dutch diet with regular energy density, without added umami (MSG)

Otros nombres:
  • regED/-MSG

During this intervention, participants will receive a Dutch diet with regular energy density, with added umami (MSG). Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • regED/+MSG

During this intervention, participants will receive a Dutch diet with lowered energy density, with added umami (MSG). Energy density will be lowered by substituting regular products for lower-fat, lower-sugar or higher water versions. Added umami will represent Dutch MSG intake levels of around the 95th percentile, which is about 55-60 mg/kg body weight.

Otros nombres:
  • lowED/+MSG

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Food intake (kcal)
Periodo de tiempo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Difference between interventions in daily food intake, averaged over two weeks. Food intake is defined as total daily energy intake from meal, snack and drink consumption. Food intake will be measured by weighing breakfast, lunch and dinner intake in grams, which will be converted to energy (kcal). Snack and drink consumption will be recorded and converted to energy (kcal) as well. Food intake is measured daily, and averaged over each intervention.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Dietary satisfaction
Periodo de tiempo: Measured at day 14 (end) of each intervention.

Difference in dietary satisfaction scores between interventions, measured with the dietary satisfaction questionnaire (DSat-45). Difference between dietary satisfaction scores will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Appetite and thirst ratings
Periodo de tiempo: From start to end of each intervention (day 1 to day 14, day 19 to day 42 and day 56 to day 70).

Appetite and thirst ratings will be measured six times daily (before three main meals and at three random times each day). Difference between average appetite and thirst ratings will be compared between the three interventions.

From start to end of each intervention (day 1 to day 14, day 19 to day 42 and day 56 to day 70).
Taste Preference
Periodo de tiempo: Measured at day 14 (end) of each intervention.

Preference for sweet/fa, sweet, salt/fat and salt tastes will be measured using PrefQuest at the end of each intervention (day 14). Differences of preferences for these tastes will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Perceived umami taste intensity
Periodo de tiempo: Measured at day 14 (end) of each intervention.

Perceived umami taste intensity will be measured at the end of each intervention during a sensory test, during which participants will rate their perceived umami taste intensity of samples differing in food type (solid, semi-solid, liquid) and MSG concentration. Differences in perceived umami taste intensity will be compared between the three interventions.

Measured at day 14 (end) of each intervention.
Fat mass
Periodo de tiempo: Six times during each intervention (day 1, 3, 6, 8, 12 and 14).

Changes in fat mass will be measured using Bioelectrical Impedance Analysis (BIA), and compared between the three interventions.

Six times during each intervention (day 1, 3, 6, 8, 12 and 14).
Bodyweight
Periodo de tiempo: Six times during each intervention (day 1, 3, 6, 8, 12 and 14).

Changes in bodyweight will be measured using a calibrated scale, and compared between the three interventions.

Six times during each intervention (day 1, 3, 6, 8, 12 and 14).
Differences in MSG complex syndrome related complaints
Periodo de tiempo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

MSG syndrome complex related complaints will be assessed daily using an MSG tolerance questionnaire. Number of reported complaints in differences of MSG complex syndrome related complaints will be compared between the three interventions.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Difference in adverse events or medication use
Periodo de tiempo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

The difference in Adverse events occurence, or medication use between intervention groups at the end of each intervention, adjusted for baseline differences. This will be measured daily by a questionnaire.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Difference between change in food intake over time
Periodo de tiempo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Difference between interventions in the day-to-day pattern of food intake across the two-week intervention periods. Food intake is defined as total daily energy intake from meal, snack and drink consumption. Food intake will be measured by weighing breakfast, lunch and dinner intake in grams, which will be converted to energy (kcal). Snack and drink consumption will be recorded and converted to energy (kcal) as well. Food intake is measured daily, and averaged over each intervention.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72).

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
MSG consumption
Periodo de tiempo: From start to end of each intervention (day 1-14, day 29-42 and day 57-72)

MSG will be administered based on intervention group and bodyweight of each individual participant. Daily MSG consumption will be measured by asking participants to return empty sachets that contained the MSG supplementation. Differences in MSG consumption between the interventions will be reported as a compliance measure.

From start to end of each intervention (day 1-14, day 29-42 and day 57-72)
Sex
Periodo de tiempo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Age
Periodo de tiempo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Height
Periodo de tiempo: Baseline (day 0)

Will be assessed using a stadiometer as the average of two measurements, rounded to the closest decimal. This will be done during the physical screening session.

Baseline (day 0)
Baseline medicine usage
Periodo de tiempo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Smoking status
Periodo de tiempo: Baseline (day 0)

Based on self-report in the screening questionnaire. Baseline characteristic.

Baseline (day 0)
Dietary restraint score
Periodo de tiempo: Baseline (day 0)

Measured by the Dutch Eating Behaviour Questionnaire (DEBQ).

Baseline (day 0)
Dietary taste patterns
Periodo de tiempo: Baseline (day 0)

Measured by Food Frequency Questionnaire designed to classify people on taste consumption patterns (tasteFFQ). Results will be used to describe habitual food intake based on taste (relative food intake in grams of each taste) at baseline.

Baseline (day 0)
Physical activity level
Periodo de tiempo: Measured at day 14 (end) of each intervention.

Measured using the SQUASH questionnaire with a reference period of two weeks. This is a compliance measure as participants are asked to maintain stable exercise patterns during the study period. Physical activity will be reported as a along with descriptive measures of participant characteristics.

Measured at day 14 (end) of each intervention.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

11 de febrero de 2027

Finalización primaria (Estimado)

1 de abril de 2027

Finalización del estudio (Estimado)

1 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

20 de febrero de 2026

Primero enviado que cumplió con los criterios de control de calidad

20 de febrero de 2026

Publicado por primera vez (Actual)

27 de febrero de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

12 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de noviembre de 2026

Última verificación

1 de febrero de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • NL-011508

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Individual participant data that underline the results reported in an article after de-identification will be shared.

Marco de tiempo para compartir IPD

Following the publication. No end date.

Criterios de acceso compartido de IPD

Anyone who whishes to access the data for secondary analysis must contact corresponding authors of specific publications for their approval. Next to this, they must reference the source of the data to provide appropriate credit to those who generated the data and allow searching for the studies it has supported.

Tipo de información de apoyo para compartir IPD

  • SAVIA
  • CÓDIGO_ANALÍTICO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .